An anti-tumor nanoparticle, [Gd@C82(OH)22]n, induces macrophage activation

J Nanosci Nanotechnol. 2011 Mar;11(3):2321-9. doi: 10.1166/jnn.2011.3610.

Abstract

[Gd@C82(OH)22]n, a fullerene-based nanoparticle, exhibits potent anti-tumor effects in mouse tumor-bearing models without detectable toxicity and the pathological studies revealed a massive infiltration of leukocytes in the residual tumors of [Gd@C82(OH)22]n-treated mice. We report here that [Gd@C82(OH)22]n promotes macrophages secreting pro-inflammatory cytokines IL-6 and TNF-alpha, enhances the expression of MHC-II and costimulatory molecules such as CD40 and CD54, increases endocytosis and cell adhesion. Furthermore, [Gd@C82(OH)22]n-treated macrophages became functionally activated as illustrated by their capacity to activate allogeneic T cells. Taken together, our results indicate that [Gd@C82(OH)22]n nanoparticle is a potent activator of macrophages, which may in part account for its potent anti-tumor effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / toxicity
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cytokines / immunology*
  • Fullerenes / administration & dosage*
  • Fullerenes / immunology
  • Fullerenes / toxicity
  • Macrophage Activation / drug effects*
  • Macrophages / drug effects*
  • Macrophages / immunology*
  • Mice
  • Mice, Inbred BALB C
  • Nanoparticles / administration & dosage*
  • Nanoparticles / toxicity
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Cytokines
  • Fullerenes